Moderna Patents – Key Insights and Stats

Moderna has a total of 1450 patents globally, out of which 248 have been granted. Of these 10068 patents, more than 49% patents are active. United States of America is where Moderna has filed the maximum number of patents, followed by Europe and Australia and it also seems reasonable as the biggest market for Moderna is USA. Parallelly, USA seems to be the main focused R&D center and is also the origin country of Moderna.

Moderna was founded in 2010 by Derrick Rossi, Kenneth Chien, Noubar Afeyan, Robert Langer, Stephane Bancel and Timothy A. Springer. Moderna doing business in Biotechnology Industry. The company offers a range of products on Biotechnology, Genetics, Health Care, Medical and Pharmaceutical, etc. As of December 2021, Moderna has a market cap of $103.38 Billion.

Do read about some of the most popular patents of Moderna which have been covered by us in this article and also you can find Moderna patents information, the worldwide patent filing activity and its patent filing trend over the years, and many other stats over Moderna patent portfolio.

How many patents does Moderna have?

Moderna has a total of 1450 patents globally. These patents belong to 277 unique patent families. Out of 1450 patents, 935 patents are active.

How many Moderna patents are Alive/Dead?

Worldwide Patents

Moderna Patents Portfolio

Patent Families

Moderna Patents

How Many Patents did Moderna File Every Year?

Moderna Filing Trend

Are you wondering why there is a drop in patent filing for the last two years? It is because a patent application can take up to 18 months to get published. Certainly, it doesn’t suggest a decrease in the patent filing.

Year of Patents Filing or GrantModerna Applications FiledModerna Patents Granted
201129
2012731
2013134
20141326
20158417
201621719
201721419
201823238
201915957
202010341
20217047

How Many Patents did Moderna File in Different Countries?

Moderna Worldwide Patents

Countries in which Moderna Filed Patents

CountryPatents
United States Of America381
Europe185
Australia109
Japan108
Hong Kong (S.A.R.)98
Canada86
China35
Singapore29
Korea (South)23
Israel20
Brazil18
Mexico17
Russian Federation14
India13
Germany11
Taiwan9
New Zealand6
Malaysia6
Argentina5
Colombia4
Chile4
Viet Nam3
Tunisia3
Peru3
Italy3
United Kingdom3
Indonesia3
Philippines3
Spain3
South Africa3
Denmark2
France1
Serbia1
Portugal1

Where are Research Centers of Moderna Patents Located?

Research Centers of Moderna Patents

10 Best Moderna Patents

WO2013052523A1 is the most popular patent in the Moderna portfolio. It has received 264 citations so far from companies like CureVac, Obsidian Therapeutics, Novartis and New England Biolabs.

Below is the list of 10 most cited patents of Moderna:

Publication NumberCitation Count
WO2013052523A1264
WO2013151671A1257
WO2013090648A1241
US8710200B2229
WO2013039857A1221
US20130245107A1218
US8822663B2200
US20140010861A1199
US20130244279A1185
US20120237975A1185

Which Companies are using Moderna Patents to Advance their Research?

If patents or patents from a particular technology area of a company receive a lot of citations, it implies that the technology is being followed and incrementally innovated by the citing companies. It also indicates that citing companies are working on similar and closely related technologies.

The top citing companies in the Moderna patent portfolio are Curevac, Translate Bio Inc and Factor Bioscience Inc.

List of the top forward citing Companies –

CompanyNumber of Patents
Curevac10
Translate Bio Inc10
Factor Bioscience Inc3
Base Pair Biotechnologies Inc2
The General Hospital Corporation2
Ribokine Llc2
Dow Chemical Company2
Boehringer Ingelheim Animal Health Usa Inc2
Arcturus Therapeutics Inc2
Nutrition & Biosciences Usa 2 Llc2

Count of 102 and 103 Type Rejections based on Moderna Patents

Top Moderna Patents used in Rejecting Most Patent Applications

Patent NumberCount of Rejected Applications
US20130156849A18
US9061059B26
US8999380B26
US9597380B26
US20140010861A16
US10124055B25
US8710200B25
US9192651B25
US20120237975A14
US10258698B23
US20140200261A13
US10323076B22
US9149506B22
US20130245107A12
US20130266640A12

What Percentage of Moderna US Patent Applications were Granted?

Moderna (Excluding its subsidiaries) has filed 365 patent applications at USPTO so far (Excluding Design and PCT applications). Out of these 150 have been granted leading to a grant rate of 58.37%.

Below are the key stats of Moderna patent prosecution at the USPTO.

Which Law Firms Filed Most US Patents for Moderna?

Law FirmTotal ApplicationsSuccess Rate
Clark Elbing9468.83%
Modernatx Inc8677.08%
Cooley Llp6778.79%
Dt Ward340.00%
Fish & Richardson2875.00%
Nelson Mullins Riley & Scarborough2652.00%
Sterne Kessler Goldstein & Fox1118.18%
Finnegan Henderson Farabow Garrett & Dunner10%
Lando & Anastasi10.00%
Wolf Greenfield & Sacks1100.00%

“Leveraging the components of our Research Engine, we empower scientists across our ecosystem to conduct rational drug design and accelerate the pace of mRNA drug discovery.”

Using mRNA as a therapy is a very different strategy than using other drug classes to treat disease. It is extremely important in human biology. mRNA is a set of instructions that tells cells how to build and send proteins to different sections of the body.

mRNA medications use natural biological processes to express proteins and achieve the therapeutic effect needed. This opens the door to the treatment of a wide range of disorders, many of which are now untreatable with existing technology. Moderna thinks that mRNA has the potential to change the way medications are found, produced, and manufactured in ways that are unprecedented in our business in terms of breadth, speed, and scale.

Moderna’s mRNA RESEARCH ENGINE services enable it to advance new product ideas into development candidates through its drug discovery efforts, and includes infrastructure to enable rapid supply of thousands of preclinical mRNAs for research involving in vitro and in vivo experiments in order to speed programmes from concept to development candidate designation.

The mRNA DESIGN STUDIO from Moderna allows for the quick creation of numerous mRNAs. Moderna’s exclusive in-house digital application suite includes a Sequence Designer module that allows you to customise a full mRNA with ever-improving rule sets based on our mRNA design experience. To design each mRNA sequence, mRNA DESIGN STUDIO uses cloud-based computational resources to run various algorithms we’ve built. We can supply flexible computing capacity on demand thanks to cloud-based capacity, allowing the Research Engine to power parallel intake and design of various mRNA sequences.

EXCLUSIVE INSIGHTS COMING SOON!

What are Moderna’s key innovation segments?

What Technologies are Covered by Moderna?

The chart below distributes patents filed by Moderna in different countries on the basis of the technology protected in patents. It also represents the markets where Moderna thinks it’s important to protect particular technology inventions.

R&D Focus: How Moderna search focus changed over the years?

EXCLUSIVE INSIGHTS COMING SOON!

Interested in knowing about the areas of innovation that are being protected by Moderna?

Updated on December 27, 2021

Was this article helpful?

Leave a Comment